Immunotherapy in Special Populations With Non-Small Cell Lung Cancer: What Would the Oncologist Do?
Do you know the best way to administer immunotherapy in unique patients with non-small cell lung cancer (NSCLC)?
Credit available for this activity expires: 10/27/24
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997794?ecd=bdc_podcast_libsyn_mscpedu
Create your
podcast in
minutes
It is Free